A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects

NCT03715829 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Non-segmental Vitiligo

Interventions

DRUG: PF-06651600
DRUG: PF-06651600
DRUG: PF-06651600
DRUG: PF-06651600
DRUG: PF-06651600
DRUG: placebo
DRUG: PF06700841
DEVICE: narrow-band UVB phototherapy

Sponsor

Pfizer